07:00 AM EDT, 09/12/2025 (MT Newswires) -- Eli Lilly ( LLY ) lost its appeal of a $183.7 million judgment in a whistleblower lawsuit accusing the company of defrauding Medicaid, Reuters reported on Thursday.

The 7th US Circuit Court of Appeals in Chicago upheld a jury finding that Eli Lilly ( LLY ) knowingly concealed retroactive drug price increases and failed to rebate Medicaid on the higher prices, the report said.

The court said jurors heard "ample evidence" that Eli Lilly ( LLY ) chose to obfuscate rather than conduct a reasonable inquiry, according to the report.

Whistleblower Ronald Streck, a lawyer and pharmacist, had argued that the judgment should have been higher, but the appeals court panel rejected his claim.

Eli Lilly ( LLY ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)